Also known as astrazeneca
AstraZeneca is a biopharmaceutical company headquartered in Cambridge, United Kingdom, whose medicines are used by millions of patients worldwide. It describes itself as science-led and works across several therapy areas, including oncology, respiratory and immune-mediated diseases. The company reports that in the first nine months of its latest reporting period total revenue rose 7% and Core EPS rose 14%, with four new medicine approvals and 12 positive Phase III readouts. Pascal Soriot is its Executive Director. It is classed in this directory as a corporate investor.
Browse more corporate investors and other institutional investors by location and type in the LPbacked limited-partner database.
AstraZeneca is a corporate investor based in Cambridge, United Kingdom, managing approximately $112.4B in assets.
AstraZeneca is headquartered in Cambridge, United Kingdom.
AstraZeneca manages approximately $112.4B in assets under management.
AstraZeneca was founded in 1998.
AstraZeneca focuses on Buyout, Expansion / Late Stage, Venture (General), Biotechnology, Healthcare, Healthcare IT, Healthcare Specialists, Pharmaceuticals.
Verified contact details, key decision-makers, and investment preferences for AstraZeneca are available on LPbacked. Create a free account to access them.